UVR, vitamin D and three autoimmune diseases - Multiple sclerosis, type 1 diabetes, rheumatoid arthritis

Photochemistry and Photobiology

Volumn 81, Issue 6, 2005, Pages 1267-1275

  Ponsonby, A L ^a   Lucas, R M ^b   Van Der Mei, I A F ^c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b The Australian National University   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

AUTOIMMUNE DISEASE; GENETICS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; PHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; ULTRAVIOLET RADIATION;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOSUPPRESSION; MULTIPLE SCLEROSIS; ULTRAVIOLET RAYS; VITAMIN D;

EID: 29844438189     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/2005-02-15-IR-441     Document Type: Review

References (96)

1. Ponsonby, A. L., A. McMichael and I. van der Mei (2002) Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181-182, 71-78.
2. Mackay, I. R. (2000) Science, medicine, and the future: tolerance and autoimmunity. BMJ. 321, 93-96.
3. Parkin, J. and B. Cohen (2001) An overview of the immune system. Lancet 357, 1777-1789.
4. Davidson, A. and B. Diamond (2001) Autoimmune diseases. N. Engl. J. Med. 345, 340-350.
5. Hogancamp, W. E., M. Rodriguez and B. G. Weinshenker (1997) The epidemiology of multiple sclerosis. Mayo Clin. Proc. 72, 871-878.
6. EURODIAB ACE Study Group (2000) Variation and trends in incidence of childhood diabetes in Europe. Lancet 355, 873-876.
7. Bach, J. F. (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911-920.
8. Diffey, B. L. (2002) Sources and measurement of ultraviolet radiation. Methods 28, 4-13.
9. Roy, C. R., H. P. Gies and S. Toomey (1995) The solar UV radiation environment: measurement techniques and results. J. Photochem. Photobiol. B Biol. 31, 21-27.
10. Roy, C. R., H. P. Gies, D. J. Lugg, S. Toomey and D. W. Tomlinson (1998) The measurement of solar ultraviolet radiation. Mutat. Res. 422, 7-14.
11. McKenzie, R. L., L. O. Bjorn, A. Bais and M. Ilyasad (2003) Changes in biologically active ultraviolet radiation reaching the Earth's surface. Photochem. Photobiol. Sci. 2, 5-15.
12. Holick, M. F. (1994) McCollum Award Lecture, 1994: vitamin D7 - new horizons for the 21st century. Am. J. Clin. Nutr. 60, 619-630.
13. Vieth, R. (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 69, 842-856.
14. Aubin, F. (2003) Mechanisms involved in ultraviolet light-induced immunosuppression. Eu. J. Dermatol. 13, 515-523.
15. Halliday, G. M., R. Bestak, K. S. Yuen, L. L. Cavanagh and R. S. Barnetson (1998) UVA-induced immunosuppression. Mutat. Res. 422, 139-145.
16. Akdis, C. A. and K. Blaser (2001) Mechanisms of interleukin-10-mediated immune suppression. Immunology 103, 131-136.
17. Ullrich, S. E. (2002) Photoimmune suppression and photocarcinogenesis. Front Biosci. 7, 684-703.
18. Rutella, S. and R. M. Lemoli (2004) Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications, Immunol. Lett. 94, 11-26.
19. Sakaguchi, S., N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, M. Itoh, Y. Kuniyasu, T. Nomura, M. Toda and T. Takahashi (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18-32.
20. WHO (1994) Ultraviolet radiation. In An Authoritatative Scientific Review of Environmental and Health Effects of UV, with Reference To Global Ozone Layer Depletion. Environmental Health Criteria 160. World Health Organization, Geneva.
21. Halliday, G. M., S. N. Byrne, J. M. Kuchel, T. S. Poon and R. S. Barnetson (2004) The suppression of immunity by ultraviolet radiation: UVA, nitric oxide and DNA damage. Photochem. Photobiol. Sci. 3, 736-740.
22. Yuen, K. S., M. R. Nearn and G. M. Halliday (2002) Nitric oxide-mediated depletion of Langerhans cells from the epidermis may be involved in UVA radiation-induced immunosuppression. Nitric Oxide 6, 313-318.
23. Mathieu, C., E. van Etten, B. Decallonne, A. Guilietti, C. Gysemans, R. Bouillon, L. Overbergh (2004) Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J. Steroid Biochem. Mol. Biol. 89-90, 449-452.
24. Lemire, J. M. (1995) Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 53, 599-602.
25. Penna, G. and L. Adorini (2000) 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 164, 2405-2411.
26. Adorini, L. (2003) Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann. N. Y. Acad. Sci. 987, 258-261.
27. Hayes, C. E, F. E. Nashold, K. M. Spach and L. B. Pedersen (2003) The immunological functions of the vitamin D endocrine system. Cell. Mol. Biol. (Noisy-le-Grand) 49, 277-300.
28. Tokuda, N. and R. B. Levy (1996) 1,25-dihydroxyvitamin D3 stimulates phagocytosis but suppresses HLA-DR and CD13 antigen expression in human mononuclear phagocytes. Proc. Soc. Exp. Biol. Med. 211, 244-250.
29. Garssen, J. and H. van Loveren (2001) Effects of ultraviolet exposure on the immune system. Crit. Rev. Immunol. 21, 359-397.
30. Luger, T. A., T. E. Scholzen, T. Brzoska and M. Bohm (2003) New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N. Y. Acad. Sci. 994, 133-140.
31. Seiffert, K. and R. D. Granstein (2002) Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 28, 97-103.
32. Cajochen, C., M. Munch, S. Kobialka, K. Krauchi, R. Steiner, P. Oelhafen, S. Orgul and A. Wirz-Justice (2005) High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J. Clin. Endocrinol. Metab. 90, 1311-1316.
33. Liebmann, P. M., A. Wolfler, P. Felsner, D. Hofer and K. Schauenstein (1997) Melatonin and the immune system. Int. Arch. Allergy Immunol. 112, 203-211.
34. Maestroni, G. J. (2001) The immunotherapeutic potential of melatonin. Expert Opin. Investig. Drugs 10, 467-476.
35. Harrison's Principles of Internal Medicine - Online version (2005) (Edited by Kasper D. L., E. Braunwald, A. S. Fauci, S. L. Hauser, D. L. Longo, J. L. Jameson and K. J. Isselbacher). McGraw Hill Companies, Inc., New York. www.accessmedicine.com/content
36. Page, W. F., J. F. Kurtzke, F. M. Murphy and J. E. Norman, Jr. (1993) Epidemiology of multiple sclerosis in U.S. veterans: V. Ancestry and the risk of multiple sclerosis. Ann. Neurol. 33, 632-639.
37. McGuigan, C., A. McCarthy, C. Quigley, L. Bannan, S. A. Hawkins and M. Hutchinson (2004) Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity. J. Neurol. Neurosurg. Psychiatry 75, 572-576,
38. McMichael, A. J. and A. J. Hall (1997) Does immunosuppressive ultraviolet radiation explain the latitude gradient for multiple sclerosis? Epidemiology 8, 642-645.
39. Acheson, E. D., C. A. Bachrach and F. M. Wright (1960) Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr. Scand. 35 (Suppl 147), 132-147.
40. Udelhofen, P. M., P. Gies, C. Roy and W. J. Randel (1999) Surface UV radiation over Australia, 1979-1992: Effects of ozone and cloud cover changes on variations of UV radiation. J. Geophys. Res. 104, 19135-19159.
41. McLeod, J. G., S. R. Hammond and J. F. Hallpike (1994) Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results. Med. J. Aust. 160, 117-122.
42. Hammond, S. R., D. R. English and J. G. McLeod (2000) The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 123 (Pt 5), 968-974.
43. van der Mei, I., A. L. Ponsonby, L. Blizzard, and T. Dwyer (2001) Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 20, 168-174.
44. Gies, H. P., C. R. Roy, S. Toomey and D. W. Tomlinson (1994) Australian radiation laboratory (ARL) solar-UVR measurement network: calibration and results. Ultraviolet Tech. 2282, 274-284.
45. Templer, D. I., N. H Trent, D. A. Spencer, A. Trent, M. D. Corgiat, P. B. Mortensen and M. Gorton (1992) Season of birth in multiple sclerosis. Acta Neurol. Scand. 85, 107-109.
46. James, W. H. (1991) Birth order in multiple sclerosis. Acta Neurol. Scand. 84, 75-77.
47. Torrey, E. F., J. Miller, R. Rawlings and R. H. Yolken (2000) Seasonal birth patterns of neurological disorders. Neuroepidemiology 19, 177-185.
48. Sadovnick, A. D. and I. M. Yee (1994) Season of birth in multiple sclerosis. Acta Neurol. Scand. 89, 190-191.
49. Salemi, G., P. Ragonese, P. Aridon, A. Reggio, A. Nicoletti, D. Buffa, S. Conte and G. Savettieri (2000) Is season of birth associated with multiple sclerosis? Acta Neurol. Scand. 101, 381-383.
50. Bharanidharan, P. (1997) Monthly distribution of multiple sclerosis patients' births. Int. J. Biometeorol. 40, 117-118.
51. Willer, C. J., D. A. Dyment, A. D. Sadovnick, P. M. Rothwell, T. J. Murray and G. C. Ebers (2005) Timing of birth and risk of multiple sclerosis: population based study. BMJ 330, 120.
52. McGrath J. J., F. P. Feron, T. H Burne, A. Mackay-Sim and D. W. Eyles (2004) Vitamin D3-implications for brain development. J. Steroid Biochem. Mol. Biol. 89-90, 557-560.
53. Chaudhuri, A. (2005) Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med. Hypotheses. 64, 608-618.
54. Zittermann, A., J. Dembinski and P. Stehle (2004) Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10. Pediatr. Allergy Immunol. 15, 242-246.
55. Jin, Y. P., J. de Pedro-Cuesta, M. Soderstrom and H. Link (1999) Incidence of optic neuritis in Stockholm, Sweden, 1990-1995: II. Time and space patterns. Arch. Neurol. 56, 975-980.
56. Sandyk, R. and G. I. Awerbuch (1993) Multiple sclerosis: relationship between seasonal variations of relapse and age of onset. Int. J. Neurosci. 71, 147-157.
57. Balashov, K. E., M. J. Olek, D. R. Smith, S. J. Khoury and H. L. Weiner (1998) Seasonal variation of interferon-gamma production in progressive multiple sclerosis. Ann. Neurol. 44, 824-828.
58. Embry, A. F., L. R. Snowdon and R. Vieth (2000) Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol. 48, 271-272.
59. Rovaris, M., G. Comi, M. P. Sormani, J. S. Wolinsky, D. Ladkani and M. Filippi (2001) Effects of seasons on magnetic resonance imaging - measured disease activity in patients with multiple sclerosis. Ann. Neurol. 49, 415-416.
60. Freedman, D. M., M. Dosemeci and M. C. Alavanja (2000) Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup. Environ. Med. 57, 418-421.
61. van der Mei, I., A. L. Ponsonby, T. Dwyer, L. Blizzard, R. Simmons, B. V. Taylor, H. Butzkueven and T. Kilpatrick (2003) Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 327, 316.
62. Munger, K. L., S. M. Zhang, E. O'Reilly, M. A. Hernan, M. J. Olek, W. C. Willett and A. Ascherio (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology. 62, 60-65.
63. Goldacre, M. J., V. Seagroatt, D. Yeates and E. D. Acheson (2004) Skin cancer in people with multiple sclerosis: a record linkage study. J. Epidemiol. Community Health 58, 142-144.
64. Goldberg, P., M. C. Fleming and E. H. Picard (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med. Hypotheses. 21, 193-200.
65. Mahon, B. D., S. A. Gordon, J. Cruz, F. Cosman and M. T. Cantorna (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J. Neuroimmunol. 134, 128-132.
66. Letterio, J. J. and A. B. Roberts (1998) Regulation of immune responses by TGF-beta. Ann Rev Immunol. 16, 137-61.
67. Diabetes Epidemiology Research International Group (1988) Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes. 37, 1113-1119.
68. Yang, Z., K. Wang, T. Li, W. Sun, Y. Li, Y. F. Chang, J. S. Dorman and R. E. LaPorte (1998) Childhood diabetes in China. Enormous variation by place and ethnic group. Diabetes Care 21, 525-529.
69. Staples, J. A., A. L. Ponsonby, L. L. Lim and A. J. McMichael (2003) Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ. Health Perspect. 111, 518-523.
70. Rothwell, P. M., A. Staines, P. Smail, E. Wadsworth and P. McKinney (1996) Seasonality of birth of patients with childhood diabetes in Britain. BMJ 312, 1456-1457.
71. Samuelsson, U., C. Johansson and J. Ludvigsson (1999) Month of birth and risk of developing insulin dependent diabetes in south east Sweden. Arch. Dis. Child. 81, 143-146.
72. Schranz, A. G. (1998) Trends in incidence of childhood type 1 diabetes in Malta. Diabetes Care 21, 194-195.
73. Rothwell, P. M., S. A. Gutnikov, P. A. McKinney, E. Schober, C. Ionescu-Tirgoviste and A. Neu (1999) Seasonally of birth in children with diabetes in Europe: multicentre cohort study. European Diabetes Study Group. BMJ 319, 887-888.
74. McKinney, P. A. (2001) Seasonally of birth in patients with childhood Type I diabetes in 19 European regions. Diabetologia 44 (Suppl. 3), 67-74.
75. The EURODIAB Substudy 2 Study Group (1999) Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 42, 51-54.
76. Stene, L. C., J. Ulriksen, P. Magnus and G. Joner (2000) Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 43, 1093-1098.
77. Hypponen, E., E. Laara, A. Reunanen, M. R. Jarvelin and S. M. Virtanen (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358, 1500-1503.
78. Harris, S. S. (2004) Vitamin D and type 1 diabetes. Am. J. Clin. Nutr. 79, 889-890.
79. Zittermann, A. (2003) Vitamin D in preventive medicine: are we ignoring the evidence? Br. J. Nutr. 89, 552-572.
80. Oelzner, P., S. Franke, A. Muller, G. Hein and G. Stein (1999) Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis. Rheumatology 38, 841-847.
81. Kroger, H., I. M. Penttila and E. M. Alhava (1993) Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand. J. Rheumatol. 22, 172-177.
82. Andjelkovic, Z., J. Vojinovic, N. Pejnovic, M. Popovic, A. Dujic, D. Mitrovic, L. Pavlica and D. Stefanovic (1999). Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin. Exp. Rheumatol. 17, 453-456.
83. Merlino, L. A., J. Curtis, T. R. Mikuls, J. R. Cerhan, L. A. Criswell and K. G. Saag (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 50, 72-77.
84. Ziegler, A. G., H. J. Baumgartl, G. Ede, M. Held, H. J. Vogt, H. J. Kolb and E. Standl (1990) Low-pigment skin type and predisposition for development of type I diabetes. Diabetes Care 13, 529-531.
85. Partridge, J. M., S. J. Weatherby, J. A. Woolmore, D. J. Highland, A. A. Fryer, C. L. Mann, M. D. Boggild, W. E. Ollier, R. C. Strange and C. P. Hawkins (2004) Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology 62, 2323-2325.
86. Rubio, J. P., M. Bahlo, N. Tubridy, J. Stankovich, R. Burfoot, H. Butzkueven, C. Chapman, L. Johnson, M. Marriott, G. Mraz, B. Tait, C. Wilkinson, B. Taylor, T. P. Speed, S. J. Foote and T. J. Kilpatrick (2004) Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis. Hum. Genet. 114, 573-580.
87. Zmuda, J. M., J. A. Cauley and R. E. Ferrell (2000) Molecular epidemiology of vitamin D receptor gene variants. Epidemiol. Rev. 22, 203-217.
88. Fukazawa, T., I. Yabe, S. Kikuchi, H. Sasaki, T. Hamada, K. Miyasaka and K. Tashiro (1999) Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J. Neurol. Sci. 166, 47-52.
89. Niino, M., T. Fukazawa, I. Yabe, S. Kikuchi, H. Sasaki and K. Tashiro (2000) Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J. Neurol. Sci. 177, 65-71.
90. Steckley, J. L., D. A. Dyment, A. D. Sadovnick, N. Risch, C. Hayes and G. C. Ebers (2000) Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology 54, 729-732.
91. McDermott, M. F., A. Ramachandran, B. W. Ogunkolade, E. Aganna, D. Curtis, B. J. Boucher, C. Snehalatha and G. A. Hitman (1997) Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 40, 971-975.
92. Chang, T. J., A. Ramachandran, B. W. Ogunkolade, E. Aganna, D. Curtis, B. J. Boucher, C. Snehalatha and G. A. Hitman (2000) Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin. Endocrinol. 52, 575-580.
93. Goertz, B., W. J. Fassbender, J. C. Williams, A. M. Marzeion, R. G. Bretzel, H. Stracke and M. N. Berliner (2003) Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin. Exp. Rheumatol. 21, 333-9.
94. Garcia-Lozano, J. R., M. F. Gonzalez-Escribano, A. Valenzuela, A. Garcia and A. Nunez-Roldan (2001) Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur. J. Immunogenet. 28, 89-93.
95. Lucas, R. M. and A. L. Ponsonby (2002) Ultraviolet radiation and health: friend and foe. Med. J. Aust. 177, 594-598.
96. Working Group of the Australian and New Zealand Bone and Mineral Society; Endocrine Society of Australia; Osteoporosis Australia (2005) Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med. J. Aust. 182, 281-285.